Health Care Technology
Company Overview of NANTHEALTH, LLC
NANTHEALTH, LLC, a transformational healthcare information technology company, provides cloud-based intelligent clinical operating systems for physicians, patients, payers, and researchers. It offers eviti|Advisor, a clinical decision support for oncologists; eviti|Advisor enterprise edition that enables identification of practice-preferred regimens for use by various providers in the practice, as well as facilitates identification of available clinical trials at the practice sites; and eviti|Connect, a Web-based platform that reduces the administrative time and tasks associated with obtaining preauthorization. The company also provides connectivity solutions, including DeviceConX (iSirona),...
9920 Jefferson Boulevard
Culver City, CA 90232
Founded in 2007
Key Executives for NANTHEALTH, LLC
Senior Vice President of Strategy
Senior Vice President of Product Development
Compensation as of Fiscal Year 2014.
NANTHEALTH, LLC Key Developments
Celgene Corporation Makes Investment in NantHealth to Advance Cancer Research for Patients
Jun 10 14
NantHealth has announced that Celgene Corporation has committed to a strategic $25 million investment in the company. This furthers the ongoing collaboration between the two entities; Celgene invested $75 million in NantBioScience. The most recent investment is targeted at leveraging NantHealth's established and acclaimed knowledge base and clinical operating system (cOS) to further aid clinicians and medical researchers in developing innovative and proven new approaches to cancer detection, prevention, diagnosis, and treatment.
LiDCO Group plc Announces Nanthealth Completes Development of Proprietary Communication Link
May 21 14
LiDCO Group plc announced that United States based NantHealth has successfully completed development of a proprietary communications link between LiDCO monitors and its own DeviceConX (formerly iSirona) system. NantHealth's DeviceConX is a software solution that collects and transmits data from medical devices into an Electronic Medical Record or Customer Information Systems. The software has been developed in accordance with the FDAs quality system regulation controls. The link will allow NantHealth's customers to access data from the company’s proprietary, minimally-invasive hemodynamic monitor via DeviceConX. The integration of critical care parameters with data derived from the LiDCOrapid and LiDCOplus monitors, will allow a fuller picture of a patient's condition and history to be displayed and accessed via DeviceConX interfaces throughout a hospital. Connecting the company’s monitors with key medical technology infrastructure will improve hospital workflows and productivity, providing another interface from which physicians can access patient data. The technology will be attractive to hospitals looking to streamline operations and improve efficiencies across technology platforms. The link will be available for LiDCOrapid V1.03 and V2.0, and LIDCOplus V4.0.
NantHealth, LLC Presents at The JPMorgan 32nd Annual Healthcare Conference, Jan-13-2014 08:30 AM
Dec 31 13
NantHealth, LLC Presents at The JPMorgan 32nd Annual Healthcare Conference, Jan-13-2014 08:30 AM. Venue: Westin St. Francis Hotel, 335 Powell Street, San Francisco, CA 94102, United States. Speakers: Patrick Soon-Shiong, Founder, Chairman, and Chief Executive officer.
Similar Private Companies By Industry
Recent Private Companies Transactions
June 18, 2014
June 5, 2014
April 15, 2014